Biogen

BIIB · NASDAQ · Biotechnology

Next results expected Oct 28, 2026 (Q3 2026). Dates can move until the company confirms them.

From the company, last 60 days

No official announcements

No 8-K filed in the last 60 days.

Sep 9Biogen CEO: We are at that inflection point where we are on a path to sustainable revenue growthCNBC

Headlines link to the original article. Lists and “should you buy” pieces are left out. Coverage is not a recommendation.

Next results expected Oct 28, 2026 (Q3 2026). Dates can move until the company confirms them.

No official announcements

No 8-K filed in the last 60 days.

Sep 9Biogen CEO: We are at that inflection point where we are on a path to sustainable revenue growthCNBC

Headlines link to the original article. Lists and “should you buy” pieces are left out. Coverage is not a recommendation.